Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection

被引:19
作者
Kocabora, M. Selim [1 ]
Durmaz, Sahan [1 ]
Kandemir, Nilay [1 ]
机构
[1] Vakif Gureba Educ & Res Hosp, Ophthalmol Clin, Istanbul, Turkey
关键词
Central serous chorioretinopathy; Intravitreal triamcinolone acetonide; Retinal vein occlusion; Anticardiolipin antibodies;
D O I
10.1007/s00417-008-0932-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
This report describes a case of central serous chorioretinopathy following intravitreal triamcinolone acetonide injection. A 42-year-old man presented with a 4-month history of decreased visual acuity (0.4) in his left eye. The left eye demonstrated macular edema due to branch retinal vein occlusion. Triamcinolone acetonide 4 mg/ 0.1 mL was injected intravitreally to treat the macular edema. Pigmentary retinal discoloration, retinal pigment epithelium leakage and a slight neurosensorial detachment with cystoid macular edema at the temporal macula were present prior to intravitreal triamcinolone injection. Three weeks after injection, visual acuity had decreased to 0.2 and metamorphopsies appeared in the left eye. A sharply demarcated serous macular elevation and a progressively increasing hyperfluorescence of the pre-existing leakage point led to the diagnosis of "exacerbation of the pre-existing asymptomatic central serous chorioretinopathy" following intravitreal triamcinolone injection. Macular elevation spontaneously resolved by the 4th month post-injection. At the 6th month, the patient experienced recurrence of a small serous detachment at the temporal macula. Central serous chorioretinopathy exacerbation may arise as a complication of intravitreal triamcinolone acetonide injection.
引用
收藏
页码:1783 / 1786
页数:4
相关论文
共 50 条
[41]   Central serous chorioretinopathy: A review [J].
Bousquet, E. ;
Provost, J. ;
Torres-Villaros, H. ;
Behar-Cohen, F. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2023, 46 (07) :791-802
[42]   Central Serous Chorioretinopathy Classification [J].
Vilela, Manuel ;
Mengue, Carolina .
PHARMACEUTICALS, 2021, 14 (01) :1-9
[43]   Traumatic central serous chorioretinopathy [J].
Steeples, Laura ;
Sharma, Vinod ;
Mercieca, Karl .
INDIAN JOURNAL OF OPHTHALMOLOGY, 2015, 63 (06) :536-538
[44]   Brachytherapy for Central Serous Chorioretinopathy [J].
Supriya Arora ;
Baldassarre D. Stea ;
Russell J. Hamilton ;
Jay Chhablani .
Ophthalmology and Therapy, 2022, 11 :1611-1616
[45]   FAMILIAL CENTRAL SEROUS CHORIORETINOPATHY [J].
van Dijk, Elon H. C. ;
Schellevis, Rosa L. ;
Breukink, Myrte B. ;
Mohabati, Danial ;
Dijkman, Greet ;
Keunen, Jan E. E. ;
Yzer, Suzanne ;
Den Hollander, Anneke I. ;
Hoyng, Carel B. ;
de Jong, Eiko K. ;
Boon, Camiel J. F. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (02) :398-407
[46]   Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for central serous chorioretinopathy [J].
Unlu, Cihan ;
Erdogan, Gurkan ;
Gezginaslan, Tugba Aydogan ;
Akcay, Betul Ilkay Sezgin ;
Kardes, Esra ;
Bozkurt, Tahir Kansu .
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2016, 79 (05) :308-311
[47]   Central serous chorioretinopathy: A review [J].
Fung, Adrian T. T. ;
Yang, Yi ;
Kam, Andrew W. W. .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (03) :243-270
[48]   Biomarkers for central serous chorioretinopathy [J].
Nkrumah, Gideon ;
Paez-Escamilla, Manuel ;
Singh, Sumit Randhir ;
Rasheed, Mohammed Abdul ;
Maltsev, Dmitri ;
Guduru, Abhilash ;
Chhablani, Jay .
THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2020, 12
[49]   Brachytherapy for Central Serous Chorioretinopathy [J].
Arora, Supriya ;
Stea, Baldassarre D. ;
Hamilton, Russell J. ;
Chhablani, Jay .
OPHTHALMOLOGY AND THERAPY, 2022, 11 (05) :1611-1616
[50]   Central serous chorioretinopathy and glucocorticoids [J].
Bouzas, EA ;
Karadimas, P ;
Pournaras, CJ .
SURVEY OF OPHTHALMOLOGY, 2002, 47 (05) :431-448